Open Orphan's (LON:ORPH) Cathal Friel talks to Proactive London after publishing their six months results - which he says reveal they are 'on target to be profitable' and plans to end year 'with substantially more cash'.
Cash and cash equivalents at half year end were £14.7m with revenue of £7.1m, with a continued focus on delivering larger contracts.
Friel also talks through the £4.3 million contract with a global top ten vaccine company that was revealed earlier in the week.
And he hints on 'advanced negotiations with various parties' for a Coronavirus challenge study in the UK.